Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cocrystal Pharma, Inc.

1.85
+0.12006.94%
Post-market: 1.930.0800+4.32%19:59 EDT
Volume:2.05M
Turnover:3.90M
Market Cap:18.82M
PE:-1.19
High:1.98
Open:1.77
Low:1.56
Close:1.73
Loading ...

Cocrystal Pharma Inc. Unveils Investor Presentation Highlighting Innovative Antiviral Drug Development Programs

Reuters
·
26 Jul

Cocrystal Pharma Inc. Concluded Annual Stockholders Meeting

Reuters
·
02 Jul

Cocrystal Pharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
20 Jun

Cocrystal Pharma Amends Bylaws to Adjust Quorum Requirements

Reuters
·
19 Jun

Cocrystal Pharma Inc. Unveils Investor Presentation Highlighting Innovative Antiviral Drug Development Programs

Reuters
·
17 Jun

BRIEF-Cocrystal Pharma’s CC-42344 Shows Strong Antiviral Potency Against 2024 H5n1 Avian Influenza Strain

Reuters
·
29 May

Cocrystal Pharma (COCP) Gets a Buy from Noble Financial

TIPRANKS
·
19 May

Cocrystal Pharma Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Cocrystal Pharma Q1 EPS $(0.23) Beats $(0.51) Estimate

Benzinga
·
15 May

BRIEF-Cocrystal Pharma Q1 Net Income USD -2.301 Million

Reuters
·
15 May

Cocrystal Pharma Inc expected to post a loss of 50 cents a share - Earnings Preview

Reuters
·
09 May

Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants

GlobeNewswire
·
24 Apr

Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference

GlobeNewswire
·
16 Apr

COCP: Norovirus Challenge Study Planned for 2025…

Zacks Small Cap Research
·
01 Apr

BRIEF-Cocrystal Pharma FY Net Income USD -17.504 Million

Reuters
·
31 Mar

Cocrystal Pharma Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
24 Mar

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

GlobeNewswire
·
14 Mar

Cocrystal Pharma And 2 Other Promising US Penny Stocks To Watch

Simply Wall St.
·
12 Feb